BioWorld

June 17, 2002

Money Raised Year To Date

Stock Winners and Losers For The Week

Clinical Trial Update: May 2002

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: May 2002

FDA Submissions, Approvals And Other Actions: May 2002

Biotech Dream Of Going Global Attainable With Capital, Products

Every start-up biotech company dreams about breakthrough product approvals, positive cash flows and becoming global. (BioWorld Financial Watch) Read More

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

BioWorld Science

Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...